The future of oncology therapeutic innovation has never been brighter. New cutting-edge medicines in development are the result of recent knowledge about disease and the pharmaceutical industry's commitment to research and development. Pennsylvania Oncology Hematology Associates maintains dedicated research staff to conduct and promote high quality clinical research. Our commitment is to provide potentially promising therapies to patients through research.